CrestPoint Capital Management’s Elevance Health ELV Stock Holding History

CrestPoint Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.16M	Hold	9,600	–	–	1.2%	17
2017 Q3	$1.82M	Sell	9,600 -300	-3%	-$57.1K	0.81%	31
2017 Q2	$1.86M	Buy	9,900 +100	+1%	+$18K	0.87%	25
2017 Q1	$1.62M	Buy	9,800 +1,200	+14%	+$191K	0.77%	33
2016 Q4	$1.24M	Hold	8,600	–	–	0.62%	48
2016 Q3	$1.08M	Buy	8,600 +700	+9%	+$90.4K	0.55%	56
2016 Q2	$1.04M	Hold	7,900	–	–	0.55%	61
2016 Q1	$1.1M	Hold	7,900	–	–	0.6%	55
2015 Q4	$1.1M	Sell	7,900 -200	-2%	-$27.6K	0.62%	47
2015 Q3	$1.13M	Sell	8,100 -1,800	-18%	-$271K	0.65%	48
2015 Q2	$1.63M	Hold	9,900	–	–	0.86%	26
2015 Q1	$1.53M	Hold	9,900	–	–	0.79%	32
2014 Q4	$1.24M	Buy	9,900 +200	+2%	+$24.7K	0.68%	44
2014 Q3	$1.16M	Hold	9,700	–	–	0.7%	43
2014 Q2	$1.04M	Hold	9,700	–	–	0.61%	60
2014 Q1	$966K	Hold	9,700	–	–	0.6%	60
2013 Q4	$896K	Buy	+9,700	New	+$862K	0.59%	60

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CrestPoint Capital Management's ELV Position: Q4 2017 in Review

CrestPoint Capital Management held its Elevance Health (ELV) position steady in Q4 2017 at 9,600 shares worth $2.16M. The position accounts for 1.2% of the portfolio, ranked #17.

CrestPoint Capital Management first reported a position in ELV in Q4 2013 and has held it in 17 quarters since. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

CrestPoint Capital Management held 9,600 shares of Elevance Health worth $2.16M as of Q4 2017.
CrestPoint Capital Management left its Elevance Health share count unchanged in Q4 2017.
Elevance Health made up 1.2% of CrestPoint Capital Management's portfolio in Q4 2017, its #17 holding.
CrestPoint Capital Management first reported a position in Elevance Health in Q4 2013 and has held it in 17 quarters since.
909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.